Page 8 - Pharmacy Compounding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

USP has proposed restrictions on beyond-use dates for many compounded medications — restrictions that may complicate your ability to treat patients. That’s why NCPA and the Alliance for Pharmacy Compounding are co-hosting a FREE 30-minute virtual briefing for prescribers on Thursday, Jan. 20, on USP’s proposed changes. The aim is to make sure physicians, physician assistants, and nurse practitioners understand what’s at stake in terms of patient access to compounded meds – and are equipped to share comments with USP before the Jan. 31 comment deadline.

Created in 2021, this PCCA award recognizes the women and men passionately advocatingfor compounding....

Amazon is accused of promoting its own products against others sold on its online platform.

Share this article Share this article ALEXANDRIA, Va., April 30, 2021 /PRNewswire/ -- A 2020 FDA-funded report published by the National Academies of Sciences, Engineering, and Medicine (NASEM) on the safety and utility of compounded hormones is compromised by potential bias, conflicts of interest and bad science—so says an independent, third-party analysis of the NASEM report released today. The Food and Drug Administration (FDA) touted the NASEM report, which recommended restrictions on compounded hormone therapy, as "independent" and "comprehensive," but in fact it was neither. That's o...

NCPA April 23, 2021 If your pharmacy does compounding, the Alliance for Pharmacy Compounding wants your opinion. They’re doing a 10-minute survey on practice areas, the scope of your compounding (and how that has changed), the size of your business, and similar areas, as well as basic demographics. The survey is conducted with support from Letco Medical, Medisca, and PCCA and will inform policymakers, media, and advocacy efforts. Please take the survey now. NCPA